Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Lim

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|September 2, 2016
Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanismYunlong Yang, Yin Zhang, Hideki Iwamoto, et al.
Cell Metabolism|June 5, 2018
Cancer Lipid Metabolism Confers Antiangiogenic Drug ResistanceHideki Iwamoto, Mitsuhiko Abe, Yunlong Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2013
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionSharon Lim, Tzuen Yih Saw, Min Zhang, et al.
Nature Communications|December 14, 2017
A miR-327-FGF10-FGFR2-mediated autocrine signaling mechanism controls white fat browningCarina Fischer, Takahiro Seki, Sharon Lim, et al.
JCI Insight|February 28, 2017
Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctionsXiaoyan Yang, Wenhai Sui, Meng Zhang, et al.
Cancer Research|December 3, 2008
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasisShian-Ying Sung, Chia-Ling Hsieh, Andrew Law, et al.
The New England Journal of Medicine|October 6, 2021
Obesity-Associated <i>GNAS</i> Mutations and the Melanocortin PathwayEdson Mendes de Oliveira, Julia M Keogh, Fleur Talbot, et al.
Journal of Medicinal Chemistry|March 25, 2016
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic CellsJoseph Cherian, Kassoum Nacro, Zhi Ying Poh, et al.
Journal of Medicinal Chemistry|April 24, 2018
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis LeukemiaHaiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Nature Communications|September 2, 2016
Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanismYunlong Yang, Yin Zhang, Hideki Iwamoto, et al.
Cell Metabolism|June 5, 2018
Cancer Lipid Metabolism Confers Antiangiogenic Drug ResistanceHideki Iwamoto, Mitsuhiko Abe, Yunlong Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2013
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionSharon Lim, Tzuen Yih Saw, Min Zhang, et al.
Nature Communications|December 14, 2017
A miR-327-FGF10-FGFR2-mediated autocrine signaling mechanism controls white fat browningCarina Fischer, Takahiro Seki, Sharon Lim, et al.
JCI Insight|February 28, 2017
Switching harmful visceral fat to beneficial energy combustion improves metabolic dysfunctionsXiaoyan Yang, Wenhai Sui, Meng Zhang, et al.
Cancer Research|December 3, 2008
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasisShian-Ying Sung, Chia-Ling Hsieh, Andrew Law, et al.
The New England Journal of Medicine|October 6, 2021
Obesity-Associated <i>GNAS</i> Mutations and the Melanocortin PathwayEdson Mendes de Oliveira, Julia M Keogh, Fleur Talbot, et al.
Journal of Medicinal Chemistry|March 25, 2016
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic CellsJoseph Cherian, Kassoum Nacro, Zhi Ying Poh, et al.
Journal of Medicinal Chemistry|April 24, 2018
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis LeukemiaHaiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, et al.
Pageof 5